AbbVie Inc.
ABBV 264.96 (1.20%) 3.17
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $468.22(B)
EV: $532.58(B)
Total Equity: $-5.89(B)
Earnings date: Oct-29-2026
P/E: 74.85
Forward P/E: 18.91
P/FCF: 25.70
P/S: 7.28
P/B: N/A
EPS: $3.5
EPS (fwd): $14.0
FCF/share: $10.3
Revenue/share: $36.4
Book value/share: $-3.4
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.80
Gross margin: 72.8%
Operating margin: 24.1%
Net margin: 9.8%
Dividend/share: $6.8
Div. yield: 2.58%
TTM Financials
Income (TTM)
Revenue$64.39(B)
Gross profit$46.87(B)
EBITDA$30.76(B)
Net income$6.31(B)
Gross margin72.8%
Operating margin24.1%
Net margin9.8%
Shares outstanding1.77(B)
Balance sheet
Total assets$135.12(B)
Current assets$33.67(B)
Total liabilities$141.00(B)
Current liabilities$41.64(B)
Cash & Short-term inv.$6.57(B)
Long-term debt$62.53(B)
Total intangibles$84.66(B)
PP&E$5.80(B)
Cash flow (TTM)
FCF$18.21(B)
CapEx$-1.30(B)
Dividends paid$-11.98(B)
Stock issued$172.00(M)
Stock repurchased$-1.50(B)
Stock-based comp.$1.07(B)
Debt issued$7.73(B)
Debt repaid$-7.31(B)